ArticleScientific reports2025
Therapeutic potential of isolated flavonoids from Anise and coriander aerial parts in antimicrobial efficacy, molecular docking, ADMET, and dynamic simulations.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Anise (Pimpinella anisum) and coriander (Coriandrum sativum) are globally esteemed for their applications in both culinary and medicinal contexts. In the present study, the quantitative analysis of total phenolic and flavonoid contents revealed that the aerial parts of anise contained elevated levels of phenolics (43.5 ± 0.23 mg/g) and flavonoids (39.8 ± 0.19 mg/g) in comparison to coriander, which exhibited values of 53.1 ± 0.18 mg/g for phenolics and 48.7 ± 0.21 mg/g for flavonoids. HPLC analysis revealed that quercetin was the most prevalent flavonoid, with chlorogenic acid and ellagic acid being the primary phenolic acids observed in both P. anisum and C. sativum. Eight flavonoids were isolated through column chromatography and silica gel thin-layer chromatography. The flavonoids identified from anise included isorhamnetin, kaempferol 3-O-rhamnoside, myricetin 3-O-rhamnoside, luteolin 7-O-β-D-glucopyranoside, and rutin, whereas coriander yielded quercetin, quercetrin, and kaempferol 3,7-O-dirhamnoside. Furthermore, the study highlighted the antimicrobial capabilities of anise and coriander extracts against pathogenic microorganisms, showing varying levels of effectiveness. Molecular docking was then utilized to examine interactions between promising compounds and antimicrobial target proteins. Results revealed that luteolin7-O-glucopyranoside, isorhamnetin, and quercetin exhibited strong binding energies, effectively binding to active sites of antimicrobial protein receptors. These interactions involved diverse molecular interactions, indicating the potential for enzyme inhibition and significant antimicrobial effects. Furthermore, in-silico ADMET profiles indicated alignment with Lipinski rules, suggesting advantageous physicochemical properties for these compounds. The MD simulations revealed stable complexes between luteolin7-O-glucopyranoside and antimicrobial receptors (1AD4, 2UV0, 2OV5, and 5TZ1). This stability was evidenced by RMSD values ranging from 0.18 to 0.40 nm, indicating minor fluctuations in RMSF values (0.10 to 0.60 nm). The SASA values ranged from 135 to 235 nm², and Rg values varied from 1.85 to 2.50 nm, offering insights into the protein complexes' shapes. These results support the compounds' potential in ongoing drug development efforts, highlighting their stability and suitability for further exploration in drug development processes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.